| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.2 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.2 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |